Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.
作者信息
Xu Yu-Yin, Chen Li, Wang Gui-Lan, Zhou Jia-Ming, Zhang Yi-Xin, Wei Yin-Ze, Zhu Yuan-Yuan, Qin Jing
机构信息
Department of Pathological Anatomy, Nantong University, Nantong, China.
Department of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
出版信息
BMC Cancer. 2023 Jul 7;23(1):636. doi: 10.1186/s12885-023-11135-3.
Abstract
摘要
相似文献
1
Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.撤稿说明：一种合成双链RNA作为Toll样受体3（TLR3）信号通路增效剂，与索拉非尼联合使用可在体内外抑制肝癌。
BMC Cancer. 2023 Jul 7;23(1):636. doi: 10.1186/s12885-023-11135-3.
2
A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.一种合成双链RNA作为Toll样受体3（TLR3）信号通路增效剂，与索拉非尼联合使用可在体外和体内抑制肝癌。
BMC Cancer. 2013 Nov 6;13:527. doi: 10.1186/1471-2407-13-527.
3
TLR3 Plays Significant Roles against HBV-Associated HCC.Toll样受体3在抗乙肝相关肝癌中发挥重要作用。
Gastroenterol Res Pract. 2015;2015:572171. doi: 10.1155/2015/572171. Epub 2015 Apr 23.
4
Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in Hepatocellular Carcinoma Cells.研究下调自噬相关基因LC3对双链RNA介导的肝癌细胞TLR3凋亡通路的影响。
Cancer Res Treat. 2017 Jan;49(1):230-245. doi: 10.4143/crt.2015.506. Epub 2016 Jun 13.
5
Effect of TLR3/dsRNA complex inhibitor on Poly(I:C)-induced airway inflammation in Swiss albino mice.Toll样受体3/双链RNA复合物抑制剂对聚肌苷酸-聚胞苷酸诱导的瑞士白化小鼠气道炎症的影响。
Environ Sci Pollut Res Int. 2023 Feb;30(10):28118-28132. doi: 10.1007/s11356-022-23987-6. Epub 2022 Nov 17.
6
Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.双链 RNA 诱导 TLR3 激活抑制血管生成并触发人肝癌细胞凋亡。
Oncol Rep. 2012 Feb;27(2):396-402. doi: 10.3892/or.2011.1538. Epub 2011 Nov 8.
7
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression.Toll样受体3激动剂与索拉非尼联合治疗可促进免疫激活并控制肝细胞癌进展。
Oncotarget. 2015 Sep 29;6(29):27252-66. doi: 10.18632/oncotarget.4583.
8
9
CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses.CD11b/CD18（Mac-1）是细胞外双链 RNA 的新型表面受体，可介导细胞炎症反应。
J Immunol. 2013 Jan 1;190(1):115-25. doi: 10.4049/jimmunol.1202136. Epub 2012 Dec 3.
10
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8 T cell activation to eradicate hepatocellular carcinoma.索拉非尼抑制放射抵抗并协同放射治疗介导的 CD8 T 细胞激活以根除肝细胞癌。
Int Immunopharmacol. 2022 Nov;112:109110. doi: 10.1016/j.intimp.2022.109110. Epub 2022 Aug 27.
本文引用的文献
1
TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.TLR3 dsRNA 激动剂抑制 HepG2.2.15 HCC 细胞的生长和侵袭。
Oncol Rep. 2012 Jul;28(1):200-6. doi: 10.3892/or.2012.1791. Epub 2012 Apr 30.
Zotero 插件